Overview
Dexlansoprazole MR in Nonerosive Reflux Disease
Status:
Unknown status
Unknown status
Trial end date:
1969-12-31
1969-12-31
Target enrollment:
0
0
Participant gender:
All
All
Summary
This study aim is to compare the efficacy of Dexlansoprazole MR intake before and after breakfast in patients with nonerosive reflux disease.Phase:
N/AAccepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
Soonchunhyang University HospitalTreatments:
Dexlansoprazole
Lansoprazole
Criteria
Inclusion Criteria:- NERD confirmed by gastroscopy
Exclusion Criteria:
- PPI medication within 2 weeks before enrollment